Infective endocarditis is associated with substantial morbidity and mortality. Several published studies have reported in-hospital mortality of 15% to 20% and 1-year mortality of 40%.
1 In the United States alone, approximately 15 000 new cases of infective endocarditis are diagnosed each year.
1 A variety of complications contribute to the high rates of morbidity and mortality in infective endocarditis, particularly heart failure (HF), which occurs in approximately 40% of patients.
2,3 Several observational studies have shown a mortality benefit for valvular surgery in infective endocarditis complicated by HF,
2 and this indication for surgery is strongly recommended in current American College of Cardiology/American Heart Association and European Society of Cardiology guidelines.
4,5